Applications

Treating C. difficile Infection

An effective, non-invasive way to overcome recurrent Clostridioides difficile infection with microbiota transfer therapy.

What is Clostridioides difficile infection?

Clostridioides (Clostridium) difficile is a toxin-producing bacterium that can proliferate when the balance of the gut flora is disrupted — typically after a course of antibiotics — causing severe, often recurrent diarrhoeal infection (CDI).

How does microbiota transfer help?

Microbiota transfer therapy (MTT) delivers a community of gut bacteria from a healthy, carefully screened donor into the patient's digestive system. These microorganisms restore microbial diversity and colonisation resistance, suppressing the overgrowth of C. difficile.

Home or hospital treatment? DiffBiome is designed for home treatment, while HospBiome is intended for more severe, hospital cases.

Who is it recommended for?

  • Patients suffering from recurrent, antibiotic-resistant CDI
  • Those for whom antibiotic therapy has not been effective
  • Patients no longer requiring hospital care but still battling the infection

Not sure which solution is right for you?

Write to us, and together we will find the most suitable therapy or service for you.

Get in touch →